Las Vegas, NV -- (SBWIRE) -- 01/10/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Newcastle Investment Corp.(NYSE:NCT), Fusion-IO, Inc.(NYSE:FIO), Merrimack Pharmaceuticals Inc(NASDAQ:MACK), Hercules Offshore, Inc.(NASDAQ:HERO)
Newcastle Investment Corp.(NYSE:NCT) was a volume gainer of 3.93 million shares and the average volume of the stock remained 3.91 million shares. The stock opened the session at $5.70 and finished at the end of the day at $5.72 and the stock surged 0.88% .The market capitalizations of the stock remained 2.01 billion. Newcastle Investment Corp. operates as a real estate investment and finance company in the United States. The company invests in and manages a portfolio consisting of real estate securities; loans; excess mortgage servicing rights; and real estate related assets, such as senior living facilities, and other assets.
For How Long NCT will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, Fusion-IO, Inc.(NYSE:FIO) exchanged 3.89 million shares and the average volume remained 2.72 million shares. The stock closed the session at $8.60 with the drop of -3.59%. Fusion-io, Inc. develops, markets, and sells storage memory platforms in the United States and internationally. It offers integrated hardware and software solutions for enterprises, hyperscale datacenters, and information systems in legacy, open, and proprietary architectures.
Why Should Investors Buy FIO After the Recent Fall? Just Go Here and Find Out
Merrimack Pharmaceuticals Inc(NASDAQ:MACK) enhanced 3.85% and its closing price was $6.20. The volume of the stock was 3.89 million shares and the average volume remained 2.51 million shares. The market capitalization of the stock remained 634.55 million. Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer in the United States. The company uses its Network Biology proprietary systems biology-based approach to biomedical research.
Why Should Investors Buy MACK After The Recent Gain? Just Go Here and Find Out
Hercules Offshore, Inc.(NASDAQ:HERO) was a volume gainer of 3.82 million shares and the average volume of the stock remained 2.54 million shares. The stock opened the session at $6.27 and finished at the end of the day at $6.03 and the stock plunged -3.21% .The market capitalizations of the stock remained 963.28 million. Hercules Offshore, Inc., together with its subsidiaries, provides shallow-water drilling and marine services to the oil and natural gas exploration and production industry worldwide. The company operates through five segments: Domestic Offshore, International Offshore, Inland, Domestic Liftboats, and International Liftboats.
Has HERO Found The Bottom and Ready To Move Up? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)